Russia will deliver to the Brazilian state 50 million doses of vaccines against a coronavirus
| Customers: Russian Direct Investment Fund (RDIF) Moscow; Financial Services, Investments and Auditing Contractors: Bahiafarma Product: Satellite V (vaccine against COVID-19 coronavirus)Project date: 2020/09
|
On September 11, 2020 the Russian Direct Investment Fund (RDIF) announced the conclusion with the secretariat of health care of the Brazilian state of Bahia of the delivery agreement up to 50 million doses of the vaccine "Sputnik of V". The cost of the transaction does not reveal.
The beginning of shipments of medicine to Brazil is planned for November, 2020. RDIF explained that if the Brazilian state regulating authorities which will also consider results of a post-registration research approve vaccine, then the agreement will allow to perform in the future supply of vaccine on all territory of the country.
Bahia will deliver the Russian medicine in all states of Brazil. The research fund of the state Bahiafarma with which RDIF also signed the agreement will be engaged in mass distribution of vaccine.
 | The government of the State of Bahia, Brazil, highly appreciates the signed agreement with a sovereign fund of the Russian Federation which will provide access to the vaccine "Sputnik of V" for the people of Brazil as soon as approval of national regulating authorities is got. Vaccine is created on the basis of human adenoviruses that is one of the safest and effective platforms in the world. We consider that the third phase of the continuing clinical trials will confirm the data obtained within phases 1 and 2 — the Minister of Health of the State of Bahia Fabio Vilash-Boash reported. |  |
As noted in RDIF, the agreement with the Brazilian partners indicates that many countries recognize importance of existence in a portfolio of the vaccines against a medicine coronavirus on the basis of adenoviral vectors of the person – carefully studied vaccinal platform which security was confirmed during decades of researches, the including 75 publications in the international scientific magazines and more than 250 clinical trials.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |